{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:46:09Z","timestamp":1792320369719,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8197081674"],"award-info":[{"award-number":["8197081674"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102803"],"award-info":[{"award-number":["82102803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272849"],"award-info":[{"award-number":["82272849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.dsx.2025.103186","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T03:27:40Z","timestamp":1736220460000},"page":"103186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases"],"prefix":"10.1016","volume":"19","author":[{"given":"Yuming","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8586-5074","authenticated-orcid":false,"given":"Lorraine Edna","family":"Onzere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Dian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaorong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangtong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.dsx.2025.103186_bib1","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.dsx.2025.103186_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103326","article-title":"Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019","volume":"22","author":"Cao","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.dsx.2025.103186_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2018.02.007","article-title":"Impact of obesity on autoimmune arthritis and its cardiovascular complications","volume":"17","author":"Van Raemdonck","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.dsx.2025.103186_bib4","article-title":"Obesity and multiple sclerosis: a mendelian randomization study","volume":"13","author":"Muraro","year":"2016","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.dsx.2025.103186_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dsx.2025.103186_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.41517","article-title":"Obesity\u2010related traits and the development of rheumatoid arthritis: evidence from genetic data","volume":"73","author":"Tang","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.dsx.2025.103186_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004227","article-title":"Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study","volume":"10","author":"Dubovyk","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.dsx.2025.103186_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcad.2021.09.007","article-title":"Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States","volume":"68","author":"Aggarwal","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"issue":"24","key":"10.1016\/j.dsx.2025.103186_bib9","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.dsx.2025.103186_bib10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of lixisenatide in early Parkinson's disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dsx.2025.103186_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108270","article-title":"Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities","volume":"239","author":"Shao","year":"2022","journal-title":"Pharmacol Therapeut"},{"issue":"16","key":"10.1016\/j.dsx.2025.103186_bib12","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.dsx.2025.103186_bib13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.dsx.2025.103186_bib14","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.dsx.2025.103186_bib15","article-title":"Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: a prospective cohort and Mendelian randomization study","volume":"5","author":"Yamazaki","year":"2024","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.dsx.2025.103186_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat Genet"},{"issue":"6460","key":"10.1016\/j.dsx.2025.103186_bib17","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.dsx.2025.103186_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.dsx.2025.103186_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108672119","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study","volume":"119","author":"Chia","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7863","key":"10.1016\/j.dsx.2025.103186_bib20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.dsx.2025.103186_bib21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/annrheumdis-2020-219065","article-title":"Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci","volume":"80","author":"Ha","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.dsx.2025.103186_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.dsx.2025.103186_bib23","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.dsx.2025.103186_bib24","article-title":"Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide","volume":"3","author":"Stuart","year":"2022","journal-title":"HGG Adv"},{"issue":"1","key":"10.1016\/j.dsx.2025.103186_bib25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s42003-021-02227-6","article-title":"Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank","volume":"4","author":"Valette","year":"2021","journal-title":"Commun Biol"},{"issue":"10","key":"10.1016\/j.dsx.2025.103186_bib26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"issue":"7944","key":"10.1016\/j.dsx.2025.103186_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.dsx.2025.103186_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"issue":"1","key":"10.1016\/j.dsx.2025.103186_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"issue":"8","key":"10.1016\/j.dsx.2025.103186_bib30","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1097\/JS9.0000000000001514","article-title":"Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials","volume":"110","author":"Sun","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.dsx.2025.103186_bib31","article-title":"Comparative analysis of semaglutide induced adverse reactions: insights from FAERS database and social media reviews with a focus on oral vs subcutaneous administration","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.dsx.2025.103186_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00403-024-02969-3","article-title":"Rare cutaneous adverse reactions associated with GLP-1 agonists: a review of the published literature","volume":"316","author":"Salazar","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"10.1016\/j.dsx.2025.103186_bib33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamacardio.2022.2333","article-title":"Joint genetic inhibition of PCSK9 and cetp and the association with coronary artery disease: a factorial mendelian randomization study","volume":"7","author":"Cupido","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.dsx.2025.103186_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003988","article-title":"Association between genetically proxied PCSK9 inhibition and prostate cancer risk: a Mendelian randomisation study","volume":"20","author":"Fang","year":"2023","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.dsx.2025.103186_bib35","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","article-title":"Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome","volume":"12","author":"Storm","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.dsx.2025.103186_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2004.02085.x","article-title":"Cellular immune responses in autoimmune thyroid disease","volume":"61","author":"Weetman","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.dsx.2025.103186_bib37","article-title":"Safety of semaglutide","volume":"12","author":"Smits","year":"2021","journal-title":"Front Endocrinol"},{"issue":"11","key":"10.1016\/j.dsx.2025.103186_bib38","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.dsx.2025.103186_bib39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","article-title":"Systemic lupus erythematosus pathogenesis: interferon and beyond","volume":"41","author":"Caielli","year":"2023","journal-title":"Annu Rev Immunol"},{"issue":"15","key":"10.1016\/j.dsx.2025.103186_bib40","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1080\/14656566.2018.1519547","article-title":"Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes?","volume":"19","author":"Doggrell","year":"2018","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.dsx.2025.103186_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100979","article-title":"GLP-1 based therapies and disease course of inflammatory bowel disease","volume":"37","author":"Villumsen","year":"2021","journal-title":"eClinicalMedicine"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402125000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402125000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:50:34Z","timestamp":1778827834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402125000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1871402125000037"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2025.103186","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2025.103186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103186"}}